Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Erratum (v117,p296)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lands, L. C.
Right arrow Articles by McKenna, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lands, L. C.
Right arrow Articles by McKenna, D.
(Chest. 1999;116:201-205.)
© 1999 American College of Chest Physicians

Lymphocyte Glutathione Levels in Children With Cystic Fibrosis*

Larry C. Lands, MD, PhD; Vijaylaxmi Grey, PhD; Argyrios A. Smountas, BSc, RRT; Violeta G. Kramer, BSPharm and Danielle McKenna, DEC

* From the Division of Respiratory Medicine (Dr. Lands and Mr. Smountas), the Department of Pediatrics (Drs. Lands and Grey), and the Department of Biochemistry (Dr. Grey, Mss. Kramer and McKenna), McGill University Medical Centre–Montreal Children's Hospital, Montreal, Quebec, Canada.

Correspondence to: Larry C. Lands, MD, PhD, Assistant Director, Respiratory Medicine, Montreal Children's Hospital, Room D-380, 2300 Tupper St, Montreal, Quebec, Canada H3H 1P3; e-mail: lanpul{at}mch.mcgill.ca

Objective: Lung disease in cystic fibrosis (CF) is characterized by a neutrophilic inflammatory response. This can lead to the production of oxidants, and to oxidative stress in the lungs. Glutathione (GSH) represents the primary intracellular antioxidant, and provides an important defense in the epithelial lining fluid. Evidence suggests that lymphocyte GSH reflects lung GSH concentrations, and so could potentially serve as a peripheral marker of lung inflammation.

Methods: We assessed peripheral blood lymphocyte GSH concentrations in 20 children (13 boys) with CF who were in stable condition at the time of evaluation. Values were compared with nutritional status and lung function parameters.

Results: Patients were 11.7 ± 3.03 years old (mean ± SD). Their percentage of ideal body weight was 101.8 ± 17.92%; FEV1, 79.5 ± 19.22% predicted; FEV1/FVC, 75.0 ± 10.08%; and residual volume (RV)/total lung capacity (TLC), 31.3 ± 10.47%. For the group, the GSH concentration was 1.31 ± 0.52 µmol/106 lymphocytes, which was not different from laboratory control values. GSH values were correlated with nutritional status (percentage of ideal body weight: r = 0.49, p < 0.03) and the degree of gas trapping (RV/TLC: r = 0.50, p < 0.03), and were correlated inversely with airflow limitation (FEV1, percent predicted: r = -0.45, p < 0.05; FEV1/FVC: r = -0.48, p < 0.04), but not with age, height, or weight (p > 0.1).

Conclusions: We interpret the inverse correlation between lymphocyte GSH concentration and lung function as a reflection of upregulation of GSH production by lung epithelial tissue in response to oxidative stress. We interpret the correlation between lymphocyte GSH concentration and nutritional status as a reflection of the role of cysteine in hepatic glutamine metabolism. Peripheral blood lymphocyte GSH concentration may potentially serve as a convenient marker of lung inflammation. Furthermore, the increased demand for GSH production in the face of ongoing inflammation suggests a potential role for supplementation with cysteine donors.

Key Words: antioxidants • inflammation • oxidative stress




This article has been cited by other articles:


Home page
ChestHome page
P. H. C. Klijn, J. van der Net, J. L. Kimpen, P. J. M. Helders, and C. K. van der Ent
Longitudinal Determinants of Peak Aerobic Performance in Children With Cystic Fibrosis
Chest, December 1, 2003; 124(6): 2215 - 2219.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Lothian, V. Grey, R. J. Kimoff, and L. C. Lands
Treatment of Obstructive Airway Disease With a Cysteine Donor Protein Supplement: A Case Report
Chest, March 1, 2000; 117(3): 914 - 916.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.